Chemtrade Logistics Income Fund (CHE-UN) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
13 Aug, 2026Executive summary
Q2 2026 revenue rose 16.5% year-over-year to $578.7 million, driven by acquisitions and higher prices in key segments, while net earnings surged to $42.9 million, a 342.5% increase year-over-year.
Adjusted EBITDA declined 7.8% to $127.3 million, impacted by lower chlor-alkali prices, sodium chlorate volumes, and a $7.0 million maintenance turnaround at the North Vancouver plant.
Distributable cash after maintenance capex dropped 40.7% to $42.4 million, or $0.38 per unit.
Cash flows from operating activities grew 8% year-over-year to $91.9 million, aided by reduced working capital needs.
Adjusted EBITDA is used as a key non-IFRS metric, excluding non-cash items like unrealized FX gains/losses.
Financial highlights
Revenue: $578.7 million (+16.5% year-over-year); Net earnings: $42.9 million (+342.5% year-over-year); Adjusted EBITDA: $127.3 million (-7.8% year-over-year).
Distributable cash after maintenance capex per unit was $0.38, down from $0.63 year-over-year.
Net debt at June 30, 2026 was $1.25 billion, with a Net debt to LTM Adjusted EBITDA ratio of 2.55x.
Maintenance capital expenditures for Q2 2026 were $42.8 million, up from $26.8 million in Q2 2025.
Growth capital expenditures for Q2 2026 were $11.4 million.
Outlook and guidance
2026 Adjusted EBITDA guidance reaffirmed at $485–$525 million, with flat year-over-year expectations and a stronger H2 required to offset a CAD 15–20 million H1 decline.
Midpoint guidance implies year-end net debt to LTM Adjusted EBITDA near 2.5x and payout ratio around 40%.
Maintenance capex timing differs from 2025, with less than half expected in H2 2026.
Vision 2030 targets mid-cycle annual Adjusted EBITDA of $550–$600 million by 2030.
Water segment outlook for 2027 remains strong, with UltraPure ramping up supply to two chip fabs in H2 2026.
Latest events from Chemtrade Logistics Income Fund
- Strong growth, disciplined capital returns, and robust 2026 outlook amid market volatility.CHE-UN
Investor presentation - Revenue up 7.9% to $503M, but Adjusted EBITDA down 5.5%; 2026 guidance reaffirmed.CHE-UN
Q1 2026 - Raised 2025 EBITDA guidance and ambitious growth targets drive strong returns and expansion.CHE-UN
Investor presentation - Record 2025 results and Vision 2030 target strong growth in water and ultrapure acid.CHE-UN
Investor presentation - Record earnings and robust growth driven by water treatment expansion and disciplined capital returns.CHE-UN
Investor presentation - Raised 2025 EBITDA guidance and announced Polytec acquisition to drive long-term growth.CHE-UN
Investor presentation - Record 2025 results, robust growth, and strong 2026 outlook driven by acid, water, and acquisitions.CHE-UN
Q4 2025 - Raised 2024 Adjusted EBITDA guidance to $445–$460M after resilient Q3 and strong cash flow.CHE-UN
Q3 2024 - Raised 2024 Adjusted EBITDA guidance to $430–$460M after strong Q2 and mixed segment results.CHE-UN
Q2 2024